ULRICH-PUR, Herbert et al. Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer. Acta Oncologica, [S. l.], v. 46, n. 2, p. 208–213, 2007. DOI: 10.1080/02841860600897868. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/26305. Acesso em: 18 may. 2026.